Logo image of MTS.MI

MIT SOCIETA DI INTERMEDIAZIO (MTS.MI) Stock Fundamental Analysis

BIT:MTS - IT0005427510 - Common Stock

2 EUR
-0.06 (-2.91%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, MTS scores 2 out of 10 in our fundamental rating. MTS was compared to 0 industry peers in the Unkown industry. MTS may be in some trouble as it scores bad on both profitability and health. MTS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MTS had positive earnings in the past year.
In the past year MTS has reported a negative cash flow from operations.
MTS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTS reported negative operating cash flow in multiple years.
MTS.MI Yearly Net Income VS EBIT VS OCF VS FCFMTS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

Industry RankSector Rank
ROA 7.3%
ROE 11.37%
ROIC 5.92%
ROA(3y)-4.76%
ROA(5y)-8.36%
ROE(3y)-6.53%
ROE(5y)-10.88%
ROIC(3y)N/A
ROIC(5y)N/A
MTS.MI Yearly ROA, ROE, ROICMTS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

Industry RankSector Rank
OM -100.16%
PM (TTM) -115.44%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTS.MI Yearly Profit, Operating, Gross MarginsMTS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTS is destroying value.
MTS has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for MTS has been reduced compared to a year ago.
MTS.MI Yearly Shares OutstandingMTS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MTS.MI Yearly Total Debt VS Total AssetsMTS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

MTS has an Altman-Z score of 1.35. This is a bad value and indicates that MTS is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.10 indicates that MTS is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACC0.68
WACC8.66%
MTS.MI Yearly LT Debt VS Equity VS FCFMTS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

MTS has a Current Ratio of 0.29. This is a bad value and indicates that MTS is not financially healthy enough and could expect problems in meeting its short term obligations.
MTS has a Quick Ratio of 0.29. This is a bad value and indicates that MTS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
MTS.MI Yearly Current Assets VS Current LiabilitesMTS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

4

3. Growth

3.1 Past

MTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 199.59%, which is quite impressive.
The Revenue for MTS has decreased by -63.33% in the past year. This is quite bad
EPS 1Y (TTM)199.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%142.05%
Revenue 1Y (TTM)-63.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%20.74%

3.2 Future

Based on estimates for the next years, MTS will show a very strong growth in Earnings Per Share. The EPS will grow by 97.38% on average per year.
Based on estimates for the next years, MTS will show a very strong growth in Revenue. The Revenue will grow by 115.48% on average per year.
EPS Next Y533.33%
EPS Next 2Y210.91%
EPS Next 3Y122.4%
EPS Next 5Y97.38%
Revenue Next Year1931.86%
Revenue Next 2YN/A
Revenue Next 3Y175.78%
Revenue Next 5Y115.49%

3.3 Evolution

MTS.MI Yearly Revenue VS EstimatesMTS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2027 2028 0 2M 4M
MTS.MI Yearly EPS VS EstimatesMTS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.76, the valuation of MTS can be described as reasonable.
MTS is valuated cheaply when we compare the Price/Earnings ratio to 27.43, which is the current average of the S&P500 Index.
MTS is valuated reasonably with a Price/Forward Earnings ratio of 10.42.
MTS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.87.
Industry RankSector Rank
PE 11.76
Fwd PE 10.42
MTS.MI Price Earnings VS Forward Price EarningsMTS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MTS.MI Per share dataMTS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTS's earnings are expected to grow with 122.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y210.91%
EPS Next 3Y122.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MIT SOCIETA DI INTERMEDIAZIO

BIT:MTS (9/5/2025, 7:00:00 PM)

2

-0.06 (-2.91%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners11.18%
Ins Owner ChangeN/A
Market Cap4.16M
Analysts80
Price Target6.17 (208.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)26.67%
EPS NY rev (3m)26.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.76
Fwd PE 10.42
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)0.17
EY8.5%
EPS(NY)0.19
Fwd EY9.6%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS-0.15
BVpS1.49
TBVpS1.49
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.3%
ROE 11.37%
ROCE 7.89%
ROIC 5.92%
ROICexc 6.29%
ROICexgc 6.45%
OM -100.16%
PM (TTM) -115.44%
GM N/A
FCFM N/A
ROA(3y)-4.76%
ROA(5y)-8.36%
ROE(3y)-6.53%
ROE(5y)-10.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.06
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales -7.87%
Interest Coverage 25.9
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z 1.35
F-Score3
WACC8.66%
ROIC/WACC0.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)318.7%
Cap/Sales(5y)237.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%142.05%
EPS Next Y533.33%
EPS Next 2Y210.91%
EPS Next 3Y122.4%
EPS Next 5Y97.38%
Revenue 1Y (TTM)-63.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%20.74%
Revenue Next Year1931.86%
Revenue Next 2YN/A
Revenue Next 3Y175.78%
Revenue Next 5Y115.49%
EBIT growth 1Y220.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5751.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.69%
OCF growth 3YN/A
OCF growth 5YN/A